These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18200823)

  • 21. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).
    Pedersen TR; Olsson AG; Faergeman O; Kjekshus J; Wedel H; Berg K; Wilhelmsen L; Haghfelt T; Thorgeirsson G; Pyörälä K; Miettinen T; Christophersen B; Tobert JA; Musliner TA; Cook TJ
    Circulation; 1998 Apr; 97(15):1453-60. PubMed ID: 9576425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of serum triglyceride levels on the risk for myocardial infarction in 12,510 middle aged males: interaction with serum cholesterol.
    Stavenow L; Kjellström T
    Atherosclerosis; 1999 Dec; 147(2):243-7. PubMed ID: 10559509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generic atorvastatin is as effective as the brand-name drug (LIPITOR
    Loch A; Bewersdorf JP; Kofink D; Ismail D; Abidin IZ; Veriah RS
    BMC Res Notes; 2017 Jul; 10(1):291. PubMed ID: 28716156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin decreases concentration of interleukin-2 in hypercholesterolemic patients after treatment for 12 weeks.
    Zubelewicz-Szkodzińska B; Szkodziński J; Romanowski W; Błazelonis A; Danikiewicz A; Muc-Wierzgoń M; Szkilnik R
    J Biol Regul Homeost Agents; 2004; 18(3-4):295-301. PubMed ID: 15786696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database.
    Jameson K; Zhang Q; Zhao C; Ramey DR; Tershakovec AM; Gutkin SW; Marrett E
    Curr Med Res Opin; 2014 Apr; 30(4):655-65. PubMed ID: 24495126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 Nov; 57(11):M747-50. PubMed ID: 12403804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipid lowering treatment in secondary prevention following myocardial infarct].
    Paragh G; Balogh Z; Boda J; Mohácsi A; Kovács P; Polgár P; Wórum F; Kakuk G
    Orv Hetil; 1997 Jul; 138(29):1849-53. PubMed ID: 9280882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
    Szczeklik A; Musiał J; Undas A; Gajewski P; Góra P; Swadźba J; Jankowski M
    J Am Coll Cardiol; 1999 Apr; 33(5):1286-93. PubMed ID: 10193729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant improvement in statin adherence and cholesterol levels after acute myocardial infarction.
    Brogaard HV; Køhn MG; Berget OS; Hansen HS; Gerke O; Mickley H; Diederichsen AC
    Dan Med J; 2012 Sep; 59(9):A4509. PubMed ID: 22951203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.
    Wong ND; Wilson PW; Kannel WB
    Ann Intern Med; 1991 Nov; 115(9):687-93. PubMed ID: 1929036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequate control of lipid levels in patients with a previous myocardial infarction.
    Ellis CJ; Zambanini A; French JK; Denton M; Johnson R; Patel H; White HD
    N Z Med J; 1998 Dec; 111(1079):464-7. PubMed ID: 9972199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
    Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
    Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive lipid-lowering strategy in patients with diabetes mellitus.
    Kanters SD; Algra A; de Bruint TW; Erkelens DW; Banga JD
    Diabet Med; 1999 Jun; 16(6):500-8. PubMed ID: 10391399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
    Tonkin AM
    Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction.
    Wang K; Chen L; Liu L; Cui Y; Zhang X; Jiang J
    Minerva Med; 2019 Apr; 110(2):101-106. PubMed ID: 29696937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of lipid-lowering treatment according to lipid level.
    Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA
    Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
    Cannon CP; Blazing MA; Giugliano RP; McCagg A; White JA; Theroux P; Darius H; Lewis BS; Ophuis TO; Jukema JW; De Ferrari GM; Ruzyllo W; De Lucca P; Im K; Bohula EA; Reist C; Wiviott SD; Tershakovec AM; Musliner TA; Braunwald E; Califf RM;
    N Engl J Med; 2015 Jun; 372(25):2387-97. PubMed ID: 26039521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.